[SKY-MOBI LIMITED John Bi Chief Financial Officer 2 Page 4 3 Sky-mobi Limited Announces Unaudited Financial Results for the Second Quarter 2014 HANGZHOU, China, August 18, 2014 Sky-mobi Limited (Sky-mobi or the Company) (NASDAQ: MOBI), a leading mobile application platform in China, today announced its unaudited financial results for the second quarter ended June 30, 2014. Second Quarter 2014]
[PERFECT WORLD ANNOUNCES SECOND QUARTER 201 4 UNAUDITED FINANCIAL RESULTS (Beijing, China August 18, 2014) Perfect World Co., Ltd. (NASDAQ: PWRD) (Perfect World or the Company), a leading online game developer and operator based in China, today announced its unaudited financial results for the second quarter ended June 30, 20 1 4 . Second Quarter 201 4 Highlights] [FORM 6-K PERFECT WORLD CO., LTD. Perfect World Plaza, Building 306, 86 Beiyuan Road Chaoyang District, Beijing 100101 Peoples Republic of China (86 10) 5780-5700 Form 20-F x Form 40-F o o o Perfect World Co., Ltd.]
[(a joint stock limited company incorporated in the Peoples Republic of China) (Stock Code: 00525) Announcement Replacement of Business Tax with Value-added Tax Company This announcement is made by Guangshen Railway Company Limited (the VAT Reform According to the Notice on Including the Railway Transportation and Postal Industries in the Pilot Program of Replacing Business Tax with Value-Added Tax]
[Sinovac Receives Tender to Supply Inactivated Hepatitis A Vaccine Healive in Beijing Under Expanded Immunization Program BEIJING, July 21, 2014 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced today that it has been selected by the Beijing Health Bureau as the sole supplier of inactivated hepatitis A vaccine in pre-filled syringe dosage] [Sinovac Receives Beijing CDC Tender to Supply Seasonal Flu Vaccine Anflu BEIJING, July 23, 2014 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced today that it has been selected by the Beijing Centers for Disease Control and Prevention ("Beijing CDC") to be a supplier of the seasonal influenza vaccine to the citizens] [Sinovac to Host Conference Call to Report Second Quarter 2014 Unaudited Financial Results BEIJING, July 25, 2014 -- Sinovac Biotech Ltd. (Nasdaq: SVA), a leading provider of biopharmaceutical products in China, today announced that it will release its unaudited financial results for the second quarter ended June 30, 2014, after market close on Thursday, August 14, 2014 EDT. The Company] []
[HOME INNS & HOTELS MANAGEMENT INC. No. 124 Caobao Road Xuhui District Shanghai 200235 People’s Republic of China August 19, 2014 VIA EDGAR Kevin Woody, Branch Chief Shannon Sobotka, Staff Accountant Angela McHale, Senior Counsel Division of Corporation Finance 100 F Street, N.E. Re: Home Inns & Hotel Management Inc. (the “Company”) Form 20-F for Fiscal Year Ended December 31,]
[EXPLANATORY NOTE This Amendment No. 1 restates the following items: · Part II, Item 7 – Management’s Discussion and Analysis of Financial Condition and Result of Operations; · Part II, Item 8 – Financial Statements and Supplementary Data - Notes 2, 3(c), 3(i), 17 and 26; · Part II, Item 9A – Controls and Procedures; and · This Amendment No.] [Subsidiary Percentage General Steel Investment Co., Ltd. British Virgin Islands 100.0 % General Steel (China) Co., Ltd. P.R.C. 100.0 % Baotou Steel – General Steel Special Steel Pipe Joint Venture Co., Ltd. P.R.C. 80.0 % Yangpu Shengtong Investment Co., Ltd. P.R.C. 99.1 % Tianjin Qiu Steel Investment Co., Ltd. P.R.C. 98.7 % Shaanxi Longmen Iron and Steel Co., Ltd. P.R.C.] [Certification I, Zuosheng Yu, certify that: 1. I have reviewed this Amendment No. 1 to the Annual Report on Form 10-K of General Steel Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the] [Certification I, John Chen, certify that: 1. I have reviewed this Amendment No. 1 to the Annual Report on Form 10-K of General Steel Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 Zuosheng Yu Chief Executive Officer August 19, 2014 John Chen Chief Financial Officer (Principal Financial Officer) August 19, 2014]
[FORM 10−Q (Mark One) [X] For the quarterly period ended: June 30, 2014 [ ] For the transition period from ____________ to _____________ CHINA BAK BATTERY, INC. Nevada 88-0442833 (State or other jurisdiction of (I.R.S. Employer Identification No.) incorporation or organization) BAK Industrial Park Meigui Street, (86-411) 6251-0619 __________________________________________________________________ Yes [X] No [_] Yes [X] No [_] Large accelerated filer] [CERTIFICATIONS I, Xiangqian Li, certify that: 1. I have reviewed this quarterly report on Form 10-Q of China BAK Battery, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [2. Information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company. th Xiangqian Li Chief Executive Officer and Interim Chief Financial Officer Accounting Officer)] [THIS DEED OF WAIVER AND RELEASE th BETWEEN (1) 深圳市比克電池有限公司 SHENZHEN BAK BATTERY CO., LTD ( 深圳市龍崗區葵涌街道比克工業園 (2) CHINA BAK BATTERY, INC. (3) BAK INTERNATIONAL LIMITED th (4) 王景輝 MR. Wang Jinghui ( 深圳市福田區香蜜湖僑香路金地香蜜山 棟 WHEREAS (A) th th By a loan agreement (Loan Agreement) dated 17 (B) Corporate Guarantees (1) th Corporate Guarantee dated 10 (2) th Corporate Guarantee]
[-- Conference call scheduled for Friday, August 15, 2014 at 8:00 AM ET -- BEIJING, Aug.14, 2014 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced today its unaudited second quarter and half year financial results for the period ended June 30, 2014. Second Quarter 2014 Financial Highlights compared to the second quarter] []
[This Form 6-K consists of: CONTENTS 2 Interim Results 2 Business Review for the First Half of the Year 4 Prospects for the Second Half of 2014 5 Management’s Discussion and Analysis (Prepared Under IFRS) 17 Share Capital Structure 17 Purchase, Sale or Redemption of Shares 17 Major Shareholding Structure 18 Material Interests and Short Positions in Shares and Underlying]
